Glenmark Pharmaceuticals Limited
NSE:GLENMARK.NS
1666.5 (INR) • At close November 8, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Omzet
| 118,130.97 | 127,254.33 | 121,741.98 | 108,060.26 | 103,972.28 | 97,050.84 | 89,435.81 | 88,638.19 | 75,030.06 | 65,215.79 | 59,236.05 | 50,123.42 | 40,206.43 | 29,490.7 | 25,006.466 | 21,160.332 | 20,092.005 | 12,515.336 | 7,575.892 | 6,120.532 | 3,806.606 |
Kosten van de omzet
| 78,634.19 | 45,369.54 | 44,597.07 | 37,438.07 | 37,666.38 | 34,075.67 | 31,095.69 | 26,598.94 | 23,971.44 | 19,660.77 | 19,121.65 | 16,536.02 | 13,453.97 | 9,918.32 | 10,193.39 | 8,750.997 | 6,757.996 | 4,574.712 | 3,817.334 | 2,714.675 | 1,793.191 |
Brutowinst
| 39,496.78 | 81,884.79 | 77,144.91 | 70,622.19 | 66,305.9 | 62,975.17 | 58,340.12 | 62,039.25 | 51,058.62 | 45,555.02 | 40,114.4 | 33,587.4 | 26,752.46 | 19,572.38 | 14,813.076 | 12,409.335 | 13,334.009 | 7,940.624 | 3,758.558 | 3,405.857 | 2,013.415 |
Brutowinstmarge
| 0.334 | 0.643 | 0.634 | 0.654 | 0.638 | 0.649 | 0.652 | 0.7 | 0.681 | 0.699 | 0.677 | 0.67 | 0.665 | 0.664 | 0.592 | 0.586 | 0.664 | 0.634 | 0.496 | 0.556 | 0.529 |
Onderzoek- en ontwikkelingskosten
| 12,258.29 | 12,500.35 | 12,787.08 | 13,186.91 | 13,205.12 | 14,480.26 | 12,251.33 | 12,622.33 | 8,175.9 | 6,014.42 | 5,998.06 | 4,115.59 | 0 | 0 | 772.758 | 882.703 | 757.73 | 432.609 | 263.344 | 326.512 | 248.073 |
Algemene en administratieve kosten
| 29,537.12 | 3,039.99 | 4,006.96 | 3,172.64 | 3,650.65 | 2,753.92 | 2,070.27 | 2,222.52 | 1,932.3 | 1,590.19 | 1,106.13 | 815.98 | 0 | 0 | 7,844.662 | 6,976.794 | 0 | 0 | 0 | 0 | 0 |
Verkoop- en marketingkosten
| 5,157.15 | 11,541.04 | 8,963.07 | 9,796.41 | 7,038.54 | 8,709.42 | 7,628.87 | 8,425.27 | 6,580.92 | 5,581.95 | 3,645.16 | 4,677.08 | 0 | 0 | 0 | 0 | 4,571.018 | 3,245.159 | 2,123.161 | 1,521.825 | 1,074.266 |
Verkoop-, algemene en administratieve kosten
| 33,362.53 | 14,581.03 | 12,970.03 | 12,969.05 | 10,689.19 | 11,463.34 | 9,699.14 | 10,647.79 | 8,513.22 | 7,172.14 | 4,751.29 | 16,305.75 | 0 | 0 | 7,844.662 | 6,976.794 | 4,571.018 | 3,245.159 | 2,123.161 | 1,521.825 | 1,074.266 |
Overige kosten
| 8,399.94 | 3,167.86 | 688.35 | 468.65 | 162.93 | 267.61 | 129.59 | 165.89 | 280.42 | 204.64 | 48.4 | 64.85 | 20,495 | 13,191.27 | 716.469 | -713.289 | 258.593 | 265.597 | 104.141 | 111.947 | 76.268 |
Bedrijfskosten
| 33,362.53 | 65,213.77 | 58,744.23 | 53,461.83 | 53,485.01 | 52,582.47 | 45,706.37 | 47,437.45 | 39,578.54 | 36,366.24 | 31,278.43 | 24,757.61 | 20,495 | 13,191.27 | 9,333.889 | 7,146.208 | 5,587.341 | 3,943.365 | 2,490.646 | 1,960.284 | 1,398.607 |
Bedrijfsresultaat
| 6,134.25 | 16,671.02 | 18,400.48 | 17,160.36 | 12,983.82 | 15,898.67 | 13,434.26 | 14,794.01 | 11,760.5 | 7,830.02 | 8,788.26 | 8,894.64 | 6,257.46 | 6,381.11 | 5,479.187 | 3,858.361 | 7,114.988 | 3,613.183 | 1,120.716 | 1,272.942 | 514.23 |
Bedrijfsresultaat ratio
| 0.052 | 0.131 | 0.151 | 0.159 | 0.125 | 0.164 | 0.15 | 0.167 | 0.157 | 0.12 | 0.148 | 0.177 | 0.156 | 0.216 | 0.219 | 0.182 | 0.354 | 0.289 | 0.148 | 0.208 | 0.135 |
Totaal overige inkomsten en kosten netto
| -5,769.3 | -7,986.51 | -3,988.02 | -3,335.61 | -2,023.06 | 407.34 | -1,965.8 | -2,000.28 | -1,432.63 | -3,245.95 | -1,867.21 | -1,492.64 | -1,376.55 | -1,565.58 | -1,640.213 | -2,574.314 | -631.68 | -384.076 | -147.196 | -172.631 | -100.578 |
Inkomen voor belasting
| 364.95 | 8,684.51 | 14,412.46 | 13,824.75 | 10,960.76 | 12,579.82 | 10,667.95 | 12,601.52 | 10,047.45 | 5,942.83 | 6,968.76 | 7,337.15 | 4,880.91 | 4,815.53 | 3,838.974 | 2,688.813 | 7,114.988 | 3,613.183 | 1,120.716 | 1,272.942 | 514.23 |
Inkomen voor belasting ratio
| 0.003 | 0.068 | 0.118 | 0.128 | 0.105 | 0.13 | 0.119 | 0.142 | 0.134 | 0.091 | 0.118 | 0.146 | 0.121 | 0.163 | 0.154 | 0.127 | 0.354 | 0.289 | 0.148 | 0.208 | 0.135 |
Belastingkosten
| 18,673.45 | 4,910.51 | 4,475.97 | 4,123.87 | 3,201.06 | 3,663.12 | 2,925.12 | 3,442.31 | 3,028.4 | 1,190.43 | 1,512.73 | 1,107.15 | 237.84 | 237.2 | 528.658 | 754.084 | 793.865 | 512.583 | 240.956 | 201.531 | 100.889 |
Nettowinst
| -15,016.68 | 2,972.45 | 9,417.11 | 9,700.38 | 7,759.7 | 8,916.59 | 7,741.91 | 9,159.67 | 7,020.98 | 4,753.1 | 5,422.75 | 6,147.43 | 4,643.07 | 4,578.33 | 3,310.316 | 1,934.729 | 6,321.327 | 3,100.6 | 879.76 | 1,071.411 | 413.606 |
Nettowinstmarge
| -0.127 | 0.023 | 0.077 | 0.09 | 0.075 | 0.092 | 0.087 | 0.103 | 0.094 | 0.073 | 0.092 | 0.123 | 0.115 | 0.155 | 0.132 | 0.091 | 0.315 | 0.248 | 0.116 | 0.175 | 0.109 |
WPA (Winst Per Aandeel)
| -53.22 | 10.53 | 33.37 | 34.38 | 27.5 | 31.6 | 27.44 | 32.46 | 25.01 | 17.52 | 20.01 | 22.91 | 17.03 | 16.78 | 12.4 | 7.7 | 25.8 | 12.99 | 3.64 | 4.49 | 1.76 |
Verwaterde WPA
| -53.22 | 10.53 | 33.37 | 34.38 | 27.5 | 31.6 | 27.43 | 32.45 | 25 | 17.52 | 20 | 22.89 | 17.01 | 16.76 | 12.4 | 7.5 | 24.9 | 11.56 | 3.21 | 4.08 | 1.75 |
EBITDA
| 11,953.31 | 25,951.56 | 24,934.37 | 21,342.43 | 18,588.57 | 17,933.39 | 17,088.42 | 20,722.35 | 14,527.72 | 10,444.13 | 11,022.65 | 10,207.35 | 7,325.36 | 7,366.86 | 6,685.291 | 7,459.502 | 8,463.463 | 4,419.848 | 1,500.256 | 1,609.805 | 725.738 |
EBITDA ratio
| 0.101 | 0.204 | 0.205 | 0.198 | 0.179 | 0.185 | 0.191 | 0.234 | 0.194 | 0.16 | 0.186 | 0.204 | 0.182 | 0.25 | 0.267 | 0.353 | 0.421 | 0.353 | 0.198 | 0.263 | 0.191 |